Folgen
Keine Story von EvaluatePharma Ltd mehr verpassen.

EvaluatePharma Ltd

Filtern
  • 22.10.2012 – 12:54

    EvaluatePharma® Launches Tracking Drugs@FDA

    London (ots/PRNewswire) - Tracking Drugs@FDA and Orange Book Patent Data Provides Unrivaled Analysis of FDA Market Intelligence EvaluatePharma [http://www.evaluatepharma.com ], the premier source for life science sector analysis and consensus forecasts, today launched a new service enhancement, Tracking Drugs@FDA, which gives clients access to the entire universe of approved FDA drugs and the related FDA document library ...

  • 02.10.2012 – 15:29

    Medtech Market to Achieve Global Sales of $440 Billion by 2018

    London And Boston (ots/PRNewswire) - - EvaluateMedTech(TM) World Preview 2018 Reveals Medtech Sales Growth Rate Forecast to Outperform Global Prescription Drug Market Between 2011 and 2018 EvaluatePharma [http://www.evaluatepharma.com ](R) the premier source for life science sector analysis and consensus forecasts, today released its EvaluateMedTech(TM) World Preview 2018 [http://www.evaluatemedtech.com/MT2018 ] report at ...

  • 28.09.2012 – 19:42

    EvaluatePharma Launches New Service for the Global Medical Device and Diagnostic Industry

    London And Boston (ots/PRNewswire) - EvaluatePharma [http://www.evaluatepharma.com ], the premier source for life science sector analysis and consensus forecasts, today announced the launch of EvaluateMedTech [http://www.evaluatemedtech.com ](TM), a new intelligence service focused on the medical device and diagnostic sector. Powered by EvaluatePharma's proven platform ...

  • 12.09.2012 – 16:23

    EvaluatePharma Appoints Alexander Karle as COO

    London And Boston (ots/PRNewswire) - EvaluatePharma [http://www.evaluategroup.com ](R), the premier source for life science sector analysis and consensus forecasts, has appointed Alexander Karle as Chief Operating Officer. Karle's experience in formulating customer-centric growth strategies and leading them to successful implementation will be instrumental in driving EvaluatePharma's continued expansion within key ...

  • 26.04.2012 – 13:02

    EvaluatePharma 2018 Outlook: Novartis #1 and Pfizer Sole USA Co in Top 5

    London (ots/PRNewswire) - EvaluatePharma Ltd, a leading source for life science sector analysis and the first to supply reliable consensus forecasts of global drug sales, revealed today that Novartis is expected to take the top spot amongst the world's pharmaceuticals manufacturers, in terms of prescription (Rx) drug sales, starting in 2014 and remains at the top ...

  • 15.11.2011 – 21:43

    Linking EudraCT and ClinicalTrials.gov Records Provides Huge Benefit

    London, November 15 (ots/PRNewswire) - EvaluatePharma Ltd, a leading source for life science sector analysis and the first to supply consensus forecasts of global drug sales, announced today the launch of its new clinical trial intelligence service, EP Clinical Trials [http://www.evaluatepharma.com/clinical ][SM]. By linking EudraCT [https://eudract.ema.europa.eu ] and ...

  • 01.11.2011 – 10:09

    Sanofi Tops Pfizer as Number One for Global Pharma Sales

    London, November 1 (ots/PRNewswire) - EvaluatePharma Ltd, a leading source for life science sector analysis and the first to supply reliable consensus forecasts of global drug sales, revealed today that Sanofi is expected to take the top spot amongst the world's pharmaceuticals manufacturers in 2012 and hold it through 2016. The French drug maker has raced up the rankings over the last decade largely through M&A activity, ...

  • 15.09.2011 – 09:32

    EvaluatePharma Japan KK - Now Open for Business in Tokyo

    London and Tokyo (ots/PRNewswire) - EvaluatePharma Ltd, the research company, is delighted to announce the official launch of EvaluatePharma Japan KK. With a team based in Tokyo, EvaluatePharma Japan KK will be ideally placed to support our clients and prospects in Japan. "Japan is a very important market for us. We have managed to build close relationships with our major customers from a distance, but it is now time for ...

  • 24.06.2011 – 17:30

    EP Vantage Wins Commentator of the Year Award at European Mediscience Awards 2011

    London (ots/PRNewswire) - EP Vantage, part of EvaluatePharma, was presented with the coveted Commentator of the Year Award at the European Mediscience Awards, sponsored by Matrix, on June 22, 2011. The award, which honours clear and concise commentary in the pharma and biotech sector, can be given to analysts, journalists, columnists, research houses or specialist ...

  • 02.02.2011 – 16:14

    Pharmaceutical Industry Bracing for Record Patent Expiries, EvaluatePharma Data Reveals

    London (ots/PRNewswire) - Thirteen US blockbusters will lose patent protection over the next two years, data from EvaluatePharma show, highlighting the challenges facing the pharmaceutical industry in the coming years. With the reporting season in full swing it is no wonder that several big pharmaceutical company chief executives have warned of tough times ahead. ...

  • 03.05.2010 – 06:03

    Pfizer Reigns Supreme After Patent Cliff as Humira Kicks Avastin off Top Spot

    London, May 3, 2010 (ots/PRNewswire) - The rheumatoid arthritis treatment Humira will replace Lipitor as the world's biggest-selling drug in 2016, but a familiar name, Pfizer, will still be the biggest seller of medicines after the patent cliff according to the World Preview 2016 report published today by EvaluatePharma, the premier provider of pharma and biotech ...